Soon-to-be-hatched start-up LXRepair measures DNA repair activity

INAC is currently incubating a promising new start-up, LXRepair, that should be launched in 2013. LXRepair has developed a new multivariate method—backed by three patents—to measure enzyme activity in DNA repair.
LXRepair’s technology targets two applications. First, to evaluate new treatments designed to interfere with DNA repair activity, like tumor-killing drugs, for example. Second, to monitor chemotherapy or radiotherapy patients during their treatment, since these treatments can interfere with DNA repair activity and cause patients to develop resistance or increased sensitivity. LXRepair’s multivariate approach gives scientists broader and more detailed information than the single-variable methods currently available.

Contact: sylvie.sauvaigo@cea.fr

Facebook

Twitter